Jesster, I agree with everything you said - but it’s honestly quite concerning.
June is almost over, and many of us were hoping July would be the month MHRA makes a decision. Yet the company remains silent. Defenders of management say they were upfront from the beginning - that no updates would be given until MHRA decides. But seriously, who thought it would drag on this long? There's only so much patience people can have.
Personally, I’ve tried to piece things together myself, just to get a sense of what’s happening with both the company and MHRA. And here’s why I think my guess might hold some weight:
NHS likely communicated with MHRA before they updated their list - that wouldn't happen in isolation.
If management knew the application had already been referred to the CHM, wouldn't they be issuing more shares to raise cash, similar to previous months? But this month’s dilution is unusually low.
That doesn’t guarantee anything, of course, but it does raise some questions worth thinking about.
Market Data 
Markets 
AI
